saikosaponin d has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, MC; Huang, YH; Lan, KH; Lan, KL; Lee, WP; Liao, SX | 1 |
| Chang, SP; Chung, CY; Hsu, WC; Hung, TC; Li, CF; Lin, CC; Lin, LT; Richardson, CD; Russell, RS; Shields, J; Tyrrell, DL; Yen, MH | 1 |
2 other study(ies) available for saikosaponin d and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Antiviral effect of saikosaponin B2 in combination with daclatasvir on NS5A resistance-associated substitutions of hepatitis C virus.
Topics: Antiviral Agents; Carbamates; Cells, Cultured; Drug Resistance, Viral; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Imidazoles; Oleanolic Acid; Pyrrolidines; Saponins; Valine; Viral Nonstructural Proteins; Virus Replication | 2019 |
Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
Topics: Animals; Antiviral Agents; Bupleurum; Cell Line; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Liver Transplantation; Male; Oleanolic Acid; Plant Extracts; Rats; Rats, Sprague-Dawley; Saponins; Virion; Virus Internalization; Virus Replication | 2015 |